HROW
Harrow Health, Inc. 8.625% Senior Notes due 2026
HROWL8
$25.27arrow_drop_down0.13%-$0.03
HROW
HROWL8
$25.27
arrow_drop_down0.13%Performance History
| Key Stats | |
|---|---|
| Open | $25.25 |
| Prev. Close | $25.30 |
| EPS | - |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $0.00 |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 25.22 | 25.28 |
| 52 Week Range | 22.05 | 25.73 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | - |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
- Sector
- Industry
- CEO
- Headquarters
- Employees
- 0
- Exchange
- NASDAQ
Keep an eye on Harrow Health, Inc. 8.625% Senior Notes due 2026
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Harrow Health, Inc. 8.625% Senior Notes due 2026's (HROWL) price per share?
The current price per share for Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) is $25.27. The stock has seen a price change of -$0.04 recently, indicating a -0.14% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)?
For Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL), the 52-week high is $25.73, which is 1.82% from the current price. The 52-week low is $22.05, the current price is 14.6% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) a growth stock?
Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) has shown an average price growth of -5.2% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Harrow Health, Inc. 8.625% Senior Notes due 2026 as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) stock price performance year to date (YTD)?
As of the latest data, Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) has a year-to-date price change of 5.29%. Over the past month, the stock has experienced a price change of -0.32%. Over the last three months, the change has been -1.33%. Over the past six months, the figure is -0.51%.
help
Is Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) a profitable company?
Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) has a net income of -$24.41M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 69.55% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 46.95%, providing insight into the company's sales performance and growth. The gross profit is $90.55M. Operating income is noted at $431K. Furthermore, the EBITDA is $0.
help
What is the market capitalization of Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)?
Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) has a market capitalization of $0. The average daily trading volume is 25.26, indicating the stock's liquidity and investor engagement.